Application of melatonin to preparation of medicine for treating loose periprosthetic chronic inflammation and bone destruction

A technology for periprosthesis and chronic inflammation is applied in the field of melatonin to prepare medicines for treating chronic inflammation and bone destruction around loose prostheses, and achieves the effects of preventing and treating prosthesis loosening, reducing bone destruction and having definite curative effect.

Active Publication Date: 2017-05-31
THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the protective effect of melatonin on chronic inflammation and b

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of melatonin to preparation of medicine for treating loose periprosthetic chronic inflammation and bone destruction
  • Application of melatonin to preparation of medicine for treating loose periprosthetic chronic inflammation and bone destruction
  • Application of melatonin to preparation of medicine for treating loose periprosthetic chronic inflammation and bone destruction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] 1. Main drugs and reagents

[0023] Melatonin (Mel), TRAP staining kit, purchased from Sigma, USA; paraformaldehyde, PBS, DAB chromogen, hematoxylin, eosin, absolute ethanol, distilled water, 10% chloral hydrate. Titanium particles were purchased from Johnson Mattheychemicals (catalog #00681; Ward Hill, Massachusetts); RANKL, OPG, TNF-α, IL-1β, IL-6 ELISA detection kits were purchased from Biosource, USA; OPG , RANKL, β-catenin, DKK1, TNF-α, IL-1β, IL-6 antibodies were purchased from Abcam, UK.

[0024] 2. Main instruments

[0025] Micro-CT (SkyScan 1176, Belgium), paraffin slicer (Leica 2135, Germany), slicer (Leica 1120, Germany), paraffin embedding machine (BMJ-Ⅱ, Changzhou, China), Axiovert 40C optical microscope (Zeiss, Germany), a microplate reader (Biotec, USA), and a set of surgical instruments.

[0026] 3. Experimental animals

[0027] Sixty healthy C57BL / J6 mice, male, weighing 19-22 g, 8-10 weeks old, clean grade, were provided by the Animal Experiment Ce...

Embodiment 2

[0038] The high-resolution micro-CT SkyScan 1076 produced by Belgium SkyScan Company was used to scan and analyze the mouse skull. Remove the specimen from the fixative and allow to dry before scanning. Referring to the method of Zhai et al., the black Ti particles on the surface of the skull were gently removed with a scalpel blade to avoid the interference of metal artifacts during scanning. Place each skull in a micro-CT test tube cup, 5 at a time, and separate each skull with a foam sheet; the skulls should be placed neatly to avoid touching the wall of the test tube. The scanning parameters were set as follows: scanning resolution 18 μm, rotation angle 180°, rotation angle increment 0.9°, voltage 80 kV, current 100 μA, exposure time 100 ms. After scanning, the SkyScan 1076 built-in software was used for 3D reconstruction of the skull. According to the method established by Wedemeyer, use CT Analyzer analysis software (CT An, SkyScan) to select a cylindrical region of in...

Embodiment 3

[0040] 1. Bone Tissue Staining and Morphometric Analysis

[0041] Handling of tissue samples

[0042] (1) Specimen fixation: wash the fresh skull specimens and soak them in 10% paraformaldehyde solution for 48 hours;

[0043] (2) Decalcification of the specimen: Put the fixed skull into a container filled with 10% EDTA decalcification solution (pH 7.4), decalcify at room temperature for 3 weeks, and change the solution every 3 days. The method of judging the success of decalcification: the needle of the syringe can pass through the skull without resistance, that is, the decalcification is successful;

[0044] (3) Specimen washing: After successful decalcification, rinse the specimen under running water for 2 hours to completely remove the components of the decalcification solution;

[0045] (4) Specimen dehydration: Pass the rinsed specimen through 50% ethanol, 60% ethanol, 70% ethanol, 80% ethanol, 90% ethanol, 95% ethanol I, 95% ethanol II, absolute ethanol I at room tempe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention provides application of melatonin to the preparation of a medicine for treating loose periprosthetic chronic inflammation and bone destruction. The chemical structural formula of melatonin is shown in a specification, and the medicine comprises a compound at pharmaceutically effective dose and a pharmaceutically acceptable carrier. According to the application, a novel medicinal prospect of melatonin is explored, a novel medicinal area is developed, the application has an exact effect of prosthesis loosening, and has the purpose of effectively preventing and treating prosthesis loosening caused by wear particles, besides, expression of inflammatory factors can be obviously reduced, inflammatory response caused by the wear particles is reduced, osteoclast activation is restrained, the formation of local new bones after osteolysis is promoted, and bone destruction caused by the wear particles is reduced.

Description

technical field [0001] The invention belongs to the technical field of new uses of medicines, and in particular relates to the use of melatonin in the preparation of medicines for treating chronic inflammation and bone destruction around loose prostheses. Background technique [0002] Chronic inflammation and bone destruction around the prosthesis caused by wear particles are the pathological basis of aseptic loosening (AL). Studies have found that after the artificial prosthesis is placed, the micro-movement between the material and the bone interface and long-term articulation Abrasion will inevitably produce a large number of wear particles, including PMMA, polyethylene and metal particles. The accumulation of wear particles around the prosthesis, on the one hand, aggravates the local friction, causing the increase of wear particles, forming a vicious cycle of dissolution-loosening-dissolution; on the other hand, wear particles can cause inflammation in the surrounding co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4045A61P19/08A61P29/00
CPCA61K31/4045
Inventor 耿德春平子川胡宣洋王亮亮徐耀增杨惠林
Owner THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products